REVENUES

9 Months Ended

Sep. 30, 2024

REVENUES

REVENUES

NOTE 4 – REVENUES

The following table summarizes the Company’s disaggregation of revenues:

	Nine Months Ended September 30,				Three Months Ended September 30,
(U.S. dollars in thousands)	2024		2023		2024		2023
Pfizer	$	11,431	$	7,972	$	3,430	$	2,304
Brazil	$	9,314	$	5,120	$	2,048	$	2,320
Chiesi	$	14,075	$	17,217	$	12,361	$	5,544
Total revenues from selling goods	$	34,820	$	30,309	$	17,839	$	10,168
Revenues from license and R&D services	$	361	$	24,699	$	120	$	177